IGGA
Iron Gate Global Advisors’s PDS Biotechnology PDSB Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-75,016
| Closed | -$89.3K | – | 94 |
|
|
2025
Q1 | $89.3K | Buy |
+75,016
| New | +$89.3K | 0.01% | 89 |
|
|
2024
Q4 | – | Sell |
-75,016
| Closed | -$287K | – | 95 |
|
|
2024
Q3 | $287K | Hold |
75,016
| – | – | 0.04% | 69 |
|
|
2024
Q2 | $220K | Hold |
75,016
| – | – | 0.04% | 83 |
|
|
2024
Q1 | $295K | Hold |
75,016
| – | – | 0.05% | 73 |
|
|
2023
Q4 | $373K | Hold |
75,016
| – | – | 0.07% | 60 |
|
|
2023
Q3 | $377K | Hold |
75,016
| – | – | 0.08% | 54 |
|
|
2023
Q2 | $377K | Hold |
75,016
| – | – | 0.08% | 57 |
|
|
2023
Q1 | $461K | Hold |
75,016
| – | – | 0.11% | 48 |
|
|
2022
Q4 | $990K | Hold |
75,016
| – | – | 0.27% | 35 |
|
|
2022
Q3 | $223K | Buy |
+75,016
| New | +$223K | 0.06% | 71 |
|
|
2021
Q3 | – | Sell |
-25,239
| Closed | -$316K | – | 117 |
|
|
2021
Q2 | $316K | Buy |
+25,239
| New | +$316K | 0.09% | 76 |
|
|
2021
Q1 | – | Sell |
-13,192
| Closed | -$28K | – | 98 |
|
|
2020
Q4 | $28K | Hold |
13,192
| – | – | 0.01% | 92 |
|
|
2020
Q3 | $31K | Hold |
13,192
| – | – | 0.01% | 93 |
|
|
2020
Q2 | $27K | Buy |
+13,192
| New | +$27K | 0.01% | 84 |
|
|
2019
Q4 | – | Sell |
-14,641
| Closed | -$49K | – | 80 |
|
|
2019
Q3 | $49K | Buy |
+14,641
| New | +$49K | 0.03% | 69 |
|